12Assessing Eustachian Tube Function Before Surgery

FThe ancillary problem Schuring foresaw

There is a recurring prophecy in otology, usually credited to Schuring and restated by Austin, that the future of ossiculoplasty will rest more on the solution of ancillary problems than on ossiculoplasty techniques [2010]. The materials have matured: titanium, hydroxyapatite and well-designed partial and total prostheses transmit sound beautifully on the bench. What still defeats them is the ear they are placed into — and the foremost of those ancillary problems is the eustachian tube. A prosthesis is a passive strut; it cannot generate the aeration it needs, so a tube that fails before surgery is a problem the reconstruction must somehow survive afterwards.

This module is deliberately narrow. It is not about tubal physiology in the abstract but about a single practical question the surgeon faces in clinic: how good is this patient’s eustachian tube, and how should the answer change what I do?The honest reply is that the tube is one of the hardest structures in the body to assess directly. You cannot see it working, you cannot biopsy its competence, and — as we will see — no single test earns the title of gold standard [2015]. Assessment is therefore an exercise in triangulation: assembling several imperfect signals into a judgement, and letting that judgement weight the surgical plan.

The stakes justify the effort. Half a century ago Holmquist showed that tympanoplasty in ears with poor tubal function fared markedly worse, and that restoring an aerated mastoid could partly compensate [1970]. Every prognostic index since has kept eustachian function near the centre: Black’s SPITE method names the Eustachian factor as one of five outcome domains [1992], and Dornhoffer’s OOPSstaging weights middle-ear and mucosal status — the operative shadow of ventilation — as a negative determinant of hearing result[2001].

FWhat you are actually trying to measure

Before reaching for a test it helps to be clear about the target. The eustachian tube does three jobs — it ventilates (equalises pressure), protects and clears — but for the ossiculoplasty surgeon the one that matters is ventilation: can the tube open often enough to keep the middle-ear cleft aerated and at a near-atmospheric pressure? A well-ventilated cleft lets the drum and chain move freely and gives a prosthesis a stable home. A chronically under-ventilated cleft goes negative, draws the drum medially, breeds adhesions and retraction pockets, and turns any reconstruction into a fight against pressure.

It also helps to know which kind of dysfunction you are looking for. The 2015 international consensus statement separates the syndromes [2015]. The one that wrecks reconstruction is chronic dilatory dysfunction: a persistent failure of opening that lets relentless mucosal gas absorption win. Distinct from it are baro-challenge-induced dysfunction (a tube that works at rest but fails against rapid ambient pressure change) and the patuloustube (abnormally open, causing autophony). The distinction is load-bearing: a ventilation tube, the right move for dilatory failure, can make a patulous ear worse. Preoperative assessment is therefore not just “good or bad tube” but which pattern.

Finally, accept the limits of what any clinic test can tell you. Tubal function fluctuates with colds, allergy and posture; a single measurement is a snapshot of a moving target. The practical aim is not a precise number but a risk weighting— enough confidence to decide whether to proceed, reinforce, ventilate or stage.

TThe bedside toolkit

Most of the assessment is done with tools already in the clinic. Each gives one imperfect signal; the skill is knowing what each can and cannot say.

• History and the contralateral ear.A patient who cannot “pop” the ear, blocks for days after flights or colds, and has a retraction pocket or effusion in the other ear is telling you about a constitutional tubal problem that the operated ear shares. The opposite ear is one of the most informative and most neglected investigations.
• ETDQ-7.McCoul’s seven-item Eustachian Tube Dysfunction Questionnaire scores seven symptoms on a 1–7 scale (composite 7–49). A mean item score of about 2.1 — a composite of roughly 14.5 or more— distinguishes patients with dysfunction from controls, giving a quick, repeatable symptom measure[2012]. It is subjective and overlaps with rhinosinusitis and migraine, so a high score flags rather than proves tubal disease.
• Otoscopy / microscopy. A retracted, adherent or atelectatic drum, a shallow middle-ear space and tympanosclerosis are visible evidence of a cleft that has been living under negative pressure. With an intact drum these signs are the clinical face of dilatory dysfunction.
• Tympanometry. Behind an intact drum, a type C trace (peak shifted to negative pressures) signals a negatively pressured cleft, and a flat type Bwith a normal canal volume indicates effusion or adhesion — both hallmarks of dilatory failure. A high-volume type B instead points to a perforation or patent ventilation tube.

Notice that none of these tests the tube’s active openingdirectly — they infer it from its consequences (symptoms, drum position, resting pressure). That is their shared blind spot, and the reason dynamic tests exist.

TDynamic and provocative tests

To probe opening itself, the surgeon turns to manoeuvres and instruments that challenge the tube and watch it respond.

• Valsalva and Toynbee.The patient forces (Valsalva) or swallows against a pinched nose (Toynbee); successful auto-inflation or auto-deflation — seen as drum movement or a pressure shift on tympanometry — is reassuring. Failure is technique-dependent and does not prove disease, and success does not guarantee good passive ventilation.
• Inflation–deflation testing.In a non-intact or grommeted ear the cleft can be pressurised and the residual pressure followed as the tube clears it. Holmquist’s work built the prognostic link between this dynamic behaviour and tympanoplasty success[1970], and it remains the classic objective test in an open ear.
• Tubomanometry. A defined nasopharyngeal pressure pulse is delivered during a swallow and the latency of the middle-ear response is captured as the R value(R ≤ 1 normal opening, R > 1 delayed, R = 0 no detectable opening). It is one of the few tests of active opening usable in an intact ear, but a diagnostic-accuracy study found the R value sensitive for opening yet not specific for non-opening — useful, not definitive [2017].
• Sonotubometry tracks sound transmitted from nose to ear-canal as the tube opens during a swallow; like its peers it has its own limitations and no claim to be a gold standard [2015].

The systematic review of these tests reaches a blunt and clinically liberating conclusion: no single test can be regarded as a gold standard [2015]. That is not a counsel of despair but of method — it tells you to combine, not to chase the one perfect measurement.

CReading the convergence, not the number

The experienced surgeon does not grade the tube from any single value; they read the convergenceof the signals. A patient whose ETDQ-7 is high, whose tympanogram is type C, who cannot Valsalva and whose other ear carries a retraction pocket has four arrows pointing the same way — that weight of evidence is far more trustworthy than any one of them alone. Conversely, an isolated abnormal R value in a symptom-free patient with a type A tympanogram and a healthy contralateral ear deserves circumspection. Assessment is pattern recognition across imperfect data, which is precisely why Austin framed eustachian competence as an experience-driven judgement rather than a measurement [2010].

And the judgement matters because the assessment predicts the outcome. In a prospective tympanoplasty series stratified by preoperative eustachian function, graft take fell from around 97% in ears with normal function to roughly 80% with partial dysfunction and only about 20% with gross dysfunction [2022]. Graft take and ossicular reconstruction are not identical endpoints, but they share one dependency — an aerated, stable middle ear — so the same preoperative gradient forecasts the durability of a prosthesis.

CTurning the assessment into a plan

Assessment earns its keep only when it changes management, and it does so along three levers. The first is timing: in an airless, adherent cleft many surgeons stage the reconstruction, clearing disease and restoring aeration — often with a ventilation tube and treatment of mucosal disease — before a prosthesis is committed. The second is design: where the assessment flags a marginal tube but reconstruction proceeds, the surgeon builds in tolerance — reinforcing the drum with cartilage at the prosthesis head to resist retraction and extrusion, keeping the malleus in the construct to distribute load, and clearing the oval- and round-window niches to preserve what aeration exists. The third is consent: a patient with poor tubal function is counselled honestly that the air–bone gap may close less reliably and that revision is more likely — a conversation the assessment makes possible.

These choices are exactly the ones the prognostic indices were built to inform. SPITE folds the Eustachian factor into a numerical forecast of ossiculoplasty success [1992], and OOPS weights middle-ear and mucosal status so that the operative findings feed back into expectation [2001]. Increasingly the tube has also become a therapeutic target rather than only a risk factor — balloon eustachian tuboplasty and adjunctive medical treatment can be deployed to improve ventilation before or alongside reconstruction where the assessment demands it.

The thread running through all of it returns us to Schuring’s prophecy. The prosthesis is no longer the limiting factor; the environment is, and the eustachian tube governs that environment. It is easy to overlook precisely because it is hard to see and harder to measure — but assessed carefully, by triangulating symptoms, tympanometry, auto-inflation and the operative view, it tells you, more reliably than any single test, whether the hearing you promise will last [2010].